Potential role for concurrent abnormalities of the cyclin D1, p16CDKN2 and p15CDKN2B genes in certain B cell non-Hodgkin's lymphomas. Functional studies in a cell line (Granta 519)

Leukemia
D M JadayelD Catovsky

Abstract

Abnormalities of several cell-cycle regulatory genes including cyclin D1, p16CDKN2 and p15CDKN2B have been described in B cell non-Hodgkin's lymphoma (B-NHL). We describe a new B-NHL cell line (Granta 519), with concurrent abnormalities of the cyclin D1, pl6CDKN2 and pl5CDKN2B genes. An independent clinical case of mantle cell NHL (Mc-NHL) with concomitant overexpression of cyclin D1, and deletion of the p16CDKN2 gene was also identified, suggesting that this combination of oncogenic aberration is a pathophysiologic contribution to a subset of NHL cases. More in-depth functional studies of this concept were facilitated by the availability of the cell line Granta 519 which was derived from a case of high-grade NHL and has a mature B cell immunophenotype. Cytogenetic analysis identified translocation t(11;14)(q13;q32) and complex rearrangements involving chromosomes 9p22, 13p21, 17pl1, and 18q21. Molecular analysis identified overexpression of cyclin D1 mRNA and biallelic deletion of the p16CDKN2 and p15CDKN2B genes. To elucidate the effect of these genetic abnormalities on the G1 control of Granta 519 cells, the level and function of the major components of the cyclinD/retinoblastoma (RB) pathway were investigated. Cyclin D1 was...Continue Reading

Citations

Dec 11, 2002·The Journal of Pathology·Raymond LaiTimothy J McDonnell
Jul 20, 2002·Leukemia Research·Hans G Drexler, Roderick A F MacLeod
Nov 21, 1998·Biochimica Et Biophysica Acta·M Ruas, G Peters
Aug 10, 2002·The Journal of Molecular Diagnostics : JMD·Ryan S RobetoryeKojo S J Elenitoba-Johnson
Jan 19, 2010·Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc·Hirotake NishimuraYoshito Sadahira
Apr 21, 2001·Molecular and Cellular Biology·J T YuD C Dean
Nov 26, 2009·Proteome Science·Henrik StranneheimJenny Flygare
Sep 2, 1999·Carcinogenesis·I P Pérez de CastroJ Fernández-Piqueras
Aug 6, 2013·Molecular Therapy : the Journal of the American Society of Gene Therapy·Tanner S MiestRoberto Cattaneo
Jul 27, 2005·British Journal of Haematology·Masakatsu HishizawaTakashi Uchiyama
Jul 9, 2003·British Journal of Haematology·Christian BognerThomas Decker
Oct 31, 2015·Pharmacology Research & Perspectives·Scott AcklerJonathan Hickson
Jul 29, 2011·International Journal of Cancer. Journal International Du Cancer·Wenqing QiDaruka Mahadevan
Oct 14, 2009·British Journal of Haematology·Christian BognerThomas Decker
Sep 8, 2004·Cancer Genetics and Cytogenetics·C RudolphB Schlegelberger
Mar 28, 2006·Leukemia Research·Hans G Drexler, Roderick A F MacLeod
Mar 9, 2012·Advances in Hematology·Sabrina DonnouSylvain Fisson
Apr 8, 2016·Epigenetics : Official Journal of the DNA Methylation Society·Pradeep Kumar KopparapuMeena Kanduri
Oct 11, 2013·Epigenetics : Official Journal of the DNA Methylation Society·Meena KanduriRichard Rosenquist

❮ Previous
Next ❯

Related Concepts

Related Feeds

Blood And Marrow Transplantation

The use of hematopoietic stem cell transplantation or blood and marrow transplantation (bmt) is on the increase worldwide. BMT is used to replace damaged or destroyed bone marrow with healthy bone marrow stem cells. Here is the latest research on bone and marrow transplantation.

B-Cell Lymphoma

B-cell lymphomas include lymphomas that affect B cells. This subtype of cancer accounts for over 80% of non-Hodgkin lymphomas in the US. Here is the latest research.

Cell Checkpoints & Regulators

Cell cycle checkpoints are a series of complex checkpoint mechanisms that detect DNA abnormalities and ensure that DNA replication and repair are complete before cell division. They are primarily regulated by cyclins, cyclin-dependent kinases, and the anaphase-promoting complex/cyclosome. Here is the latest research.